Lianzhen Lin
China National Pharmaceutical Group Corporation (China)(CN)
Publications by Year
Research Areas
SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, Long-Term Effects of COVID-19, COVID-19 Impact on Reproduction, Advanced Drug Delivery Systems
Most-Cited Works
- → Effectiveness of convalescent plasma therapy in severe COVID-19 patients(2020)2,023 cited
- → The feasibility of convalescent plasma therapy in severe COVID- 19 patients: a pilot study(2020)129 cited
- → Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan(2021)69 cited
- → Author Correction: Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan(2021)7 cited
- → COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan(2022)4 cited